0 items USD 0.00Search
- Did you mean
- cdk 4/6 inhibitors
Your search for "CDK%204%2F6%20inhibitor" gave back 8092 results.
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Cell Cycle Inhibitors market will undergo major changes...
Catalog:
Arsta
January 2022
Price: USD 3,360.00
Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) - Pipeline Review, H2...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Cyclin Dependent Kinase 4 - Pipeline Review, H2 2019 Summary Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
March 2022
Price: USD 3,500.00
Cyclin Dependent Kinase 2 (p33 Protein Kinase or Cell Division Protein Kinase 2 or CDK2 or EC 2.7.11.22) - Drugs in Development, 2021 Summary...
Catalog:
Global Markets Direct
October 2021
Price: USD 3,500.00
Cyclin Dependent Kinase 2 - Pipeline Review, H1 2020 Summary According to the recently published report 'Cyclin Dependent Kinase 2 – Pipeline...
Catalog:
Global Markets Direct
May 2020
Price: USD 3,500.00
Cyclin Dependent Kinase 1 - Pipeline Review, H2 2019 Summary According to the recently published report 'Cyclin Dependent Kinase 1 - Pipeline...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
The “Non-Tyrosine Kinase Inhibitors Industry Forecast” looks at past sales and reviews total world Non-Tyrosine Kinase Inhibitors sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2018 Summary Cyclin Dependent...
Catalog:
Global Markets Direct
November 2018
Price: USD 3,500.00
The global Non-Tyrosine Kinase Inhibitors market size was valued at US$ million in 2023. With growing demand in downstream market, the Non-Tyrosine...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Non-Tyrosine Kinase Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Highlights The global Non-Tyrosine Kinase Inhibitors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The global Non-Tyrosine Kinase Inhibitors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H2 2018 Summary Cellular Tumor...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Pipeline Review, H1 2018 Summary Cellular Tumor...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
